Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes

BACKGROUND: Patient-reported measures can be used to examine whether drug differences other than clinical efficacy have an impact on outcomes that may be important to patients. Although exenatide and insulin glargine appear to have similar efficacy for treatment of type 2 diabetes, there are several...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Secnik Boye, Kristina, Matza, Louis S, Oglesby, Alan, Malley, Karen, Kim, Sunny, Hayes, Risa P, Brodows, Robert
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2006
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1634743/
https://ncbi.nlm.nih.gov/pubmed/17034640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7525-4-80
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky